phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

Immunosuppressive Tumor Microenvironment Contributes to Tumor Progression in Diffuse Large B-Cell Lymphoma Upon Anti-CD19 Chimeric Antigen Receptor T Therapy

Researchers from Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, et al. have conducted a study entitled "Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy".

September 2, 2025


September 12 2025

September 11 2025

September 10 2025

September 9 2025

September 8 2025

September 7 2025

September 6 2025

September 5 2025

September 4 2025

September 3 2025

September 2 2025

September 1 2025

August 31 2025

August 30 2025

Angell Street Psychiatry
Copyright 2025 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy